Released Aug 14, 2012, during market hours
10-Q filed Aug 14, 2012, 45 days after period end · 0001144204-12-045521
Q2 2012 · 10-Q
Revenue—
Net Income-$6.30K-$6.30K N/M vs Q2 2011N/M vs Q1 2012
EPS Diluted$0.00$0.00 — vs Q2 2011no prior Q1 2012 on file
Operating Income-$5,031N/M
Operating Cash Flowderived-$14,287N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Net Income | -$6.30K | -$6.76K | -$5.58K |
| EPS Diluted | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR